The β-blocker atenolol is used widely as a first-line treatment for hypertension and as a reference drug in clinical trials. Prompted by a finding that the angiotensin-receptor blocker losartan ...

Drugmakers have decided to stop selling a kind of controversial fentanyl painkiller at the end of this month, the Food and Drug Administration said this week, marking an end to a controversial ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

London: EU antitrust regulators are set to fine world No. 1 generic drugmaker Teva in the coming weeks for disparaging a rival product to its blockbuster multiple sclerosis medicine Copaxone ...

The announcement came a day after the city reached an $80 million settlement over opioids with drugmaker Teva Pharmaceutical (TEVA.TA), opens new tab. Baltimore did not disclose the terms of its ...

BRUSSELS, Sept 10 (Reuters) - Teva (TEVA.TA), opens new tab, the world's largest generic drugmaker, will be hit with an EU antitrust fine in the coming weeks for disparaging a rival product to its ...